🇺🇸 FDA
Patent

US 11701338

Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross blood-brain barrier

granted A61KA61K31/305A61K31/4406

Quick answer

US patent 11701338 (Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross blood-brain barrier) held by Northwest Institute of Plateau Biology, Chinese Academy of Sciences expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwest Institute of Plateau Biology, Chinese Academy of Sciences
Grant date
Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/305, A61K31/4406, A61K47/12, A61K47/26